Emergent BioSolutions Inc (NYSE:EBS)
| 14.26 Data as of May 23 |  +0.01 / +0.07%Today’s Change | 12.50 Today|||52-Week Range 16.99 | -11.10% Year-to-Date |
Latest EBS News | Press Releases
| July Options Now Available For Emergent BioSolutions (EBS) May 20 / TheStreet.com |
Today’s Trading
| Previous close | 14.25 |
| Today’s open | 14.13 |
| Day’s range | -- - -- |
| Volume | 120,833 |
| Average volume (3 months) | 242,274 |
| Market cap | $513.3M |
| Dividend yield | -- |
Data as of 4:03pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +1.56% |
| Earnings growth (this year) | +13.85% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +3.11% |
| P/E ratio | 23.0 |
| Price/Sales | 2.05 |
| Price/Book | 1.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ECYTEndocyte Inc | +0.23 | +1.67% |
| CMRXChimerix Inc | +0.35 | +1.72% |
| SNTASynta Pharmaceutical... | -0.08 | -1.08% |
| MACKMerrimack Pharmaceut... | +0.15 | +2.94% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.21 |
| Annual revenue (last year) | $281.9M |
| Annual profit (last year) | $23.5M |
| Net profit margin | 8.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Daniel J. Abdun-Nabi |
CFO, Treasurer & Executive VP-Corporate Services Robert G. Kramer, Sr., MBA |
Corporate headquarters Rockville, Maryland |
Forecasts
